Genotyping Market Industry Trends 2018

The global genotyping market is expected to reach $17.0 Billion in 2020 from $6.2 Billion in 2015, at a CAGR of 22.3% during the forecast period of 2015 to 2020. Market growth will be attributed to the availability of a range of products for wide applications, decreasing prices of DNA sequencing, increasing incidence of and awareness on genetic diseases and personalized medicine, increasing demand for pharmacogenomics in drug discovery and development, and the rising use of genetic analysis of animal and plant livestock.

Full Report : https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html

The genotyping market studied in this report is mainly segmented by product, technology, applications, and end user. The market, by product & services, is segmented into instruments (sequencers & amplifiers, and analyzers), reagents and kits, bioinformatics software and services. Reagents & kits market is expected to grow at a CAGR of during the forecast period of 2015 to 2020. Based on application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period.
The market, by technology, is segmented into microarray, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, MALDI-TOF, and others (allele specific oligonucleotide (ASO) probes, & in situ hybridization). Sequencing is the high growth market, owing to its widening application areas of DNA sequencing technologies, technological advancements, and the availability of high-speed sequencing instruments are expected to contribute to the growth of the DNA sequencing market in the coming years.

Developed geographies like North America and Europe are saturated markets and expected to grow at a slower rate, whereas the Asian market is expected to witness the highest growth of CAGR, 25.4% from 2015 to 2020, due to the huge demand for better healthcare services, expanding per capita income, increasing ongoing clinical trials in these regions, and the increasing focus of leading players on these regions.

The key players operating in genotyping market are Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.).

Press Releases: https://www.marketsandmarkets.com/PressReleases/genotyping.asp

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441

This release was published on openPR.